Clal Biotechnology Industries Ltd. (CBI.TA)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Assaf Segal | Acting Chief Executive Officer | 1.45M | -- | -- |
| Ms. Liat Nissan | Vice President of Finance | 225k | -- | 1977 |
| Ms. Etty Kliger | Vice President of Research & Development - MediWound | 914k | -- | -- |
| Dr. Lior Rosenberg M.D. | Vice President of Medical Technologies - MediWound | 987k | -- | 1946 |
| Ms. Iris Sadeh | Accountant | -- | -- | -- |
| Ms. Shiran Manor | General Counsel & Corporate Secretary | -- | -- | -- |
| Dr. Arnon Aharon M.D. | Medical Director | -- | -- | 1969 |
Clal Biotechnology Industries Ltd.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It invests between $0.5 million and $10 million per company. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel with an additional office in Cambridge, Massachusetts. It operates as a former subsidiary of Clal Industries and Investments Ltd.
Corporate Governance
Recent Events
- Mar 29, 2021Ex-Dividend Date
Upcoming Events
Upcoming Events Information Not Available